Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to investigate the safety and feasibility of neoadjuvant PD-1 blockade alone or neoadjuvant PD-1 blockade plus TPF induction chemotherapy in subjects with resectable local advanced oral squamous cell carcinoma.
Epistemonikos ID: 736e8f45bfc6d822c82f33d7b8d695bc9b4a65e7
First added on: May 07, 2024